These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33757382)

  • 1. ANLN, Regulated by SP2, Promotes Colorectal Carcinoma Cell Proliferation via PI3K/AKT and MAPK Signaling Pathway.
    Liu Y; Cao P; Cao F; Wang S; He Y; Xu Y; Wang Y
    J Invest Surg; 2022 Feb; 35(2):268-277. PubMed ID: 33757382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
    Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
    J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway.
    Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TMEM206 promotes the malignancy of colorectal cancer cells by interacting with AKT and extracellular signal-regulated kinase signaling pathways.
    Zhao J; Zhu D; Zhang X; Zhang Y; Zhou J; Dong M
    J Cell Physiol; 2019 Jul; 234(7):10888-10898. PubMed ID: 30417481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K/Akt signaling pathways.
    Wei ZJ; Tao ML; Zhang W; Han GD; Zhu ZC; Miao ZG; Li JY; Qiao ZB
    Int J Clin Exp Pathol; 2015; 8(5):4481-91. PubMed ID: 26191138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
    Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
    Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of GLYR1 contributes to microsatellite instability colorectal cancer by targeting p21 via the p38MAPK and PI3K/AKT pathways.
    Hu Z; Long T; Ma Y; Zhu J; Gao L; Zhong Y; Wang X; Wang X; Li Z
    J Exp Clin Cancer Res; 2020 May; 39(1):76. PubMed ID: 32370786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
    Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
    Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelial‑mesenchymal transition through PI3K/AKT signaling activation.
    Ji B; Feng Y; Sun Y; Ji D; Qian W; Zhang Z; Wang Q; Zhang Y; Zhang C; Sun Y
    Oncol Rep; 2018 Oct; 40(4):1885-1896. PubMed ID: 30066935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo.
    Feng Y; Qian W; Zhang Y; Peng W; Li J; Gu Q; Ji D; Zhang Z; Wang Q; Zhang D; Sun Y
    BMC Cancer; 2019 Jun; 19(1):576. PubMed ID: 31196027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCL6B suppresses proliferation and migration of colorectal carcinoma cells through inhibition of the PI3K/AKT signaling pathway.
    Gu Y; Li A; Sun H; Li X; Zha H; Zhao J; Xie J; Zeng Z; Zhou L
    Int J Mol Med; 2018 May; 41(5):2660-2668. PubMed ID: 29393377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling.
    Chen X; Wang W; Li Y; Huo Y; Zhang H; Feng F; Xi W; Zhang T; Gao J; Yang F; Chen S; Yang A; Wang T
    J Exp Clin Cancer Res; 2021 Oct; 40(1):341. PubMed ID: 34706761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Hydrogen Inhibits Colorectal Cancer Growth via the AKT/SCD1 Signaling Pathway.
    Zhang X; Tao G; Zhao Y; Xing S; Jiang J; Liu B; Qin S
    Biomed Res Int; 2022; 2022():8024452. PubMed ID: 35528164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
    Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.
    Zhang JJ; Xu WR; Chen B; Wang YY; Yang N; Wang LJ; Zhang YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8321-8331. PubMed ID: 31646562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRR11 Promotes Proliferation and Migration of Colorectal Cancer through Activating the EGFR/ERK/AKT Pathway via Increasing CTHRC1.
    Ma H; Yang W; Wang X; Dai G
    Ann Clin Lab Sci; 2022 Jan; 52(1):86-94. PubMed ID: 35181621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. INTS6 promotes colorectal cancer progression by activating of AKT and ERK signaling.
    Ding X; Chen T; Shi Q; Nan P; Wang X; Xie D; Li J
    Exp Cell Res; 2021 Oct; 407(2):112826. PubMed ID: 34508742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer.
    Jiang T; Wang H; Liu L; Song H; Zhang Y; Wang J; Liu L; Xu T; Fan R; Xu Y; Wang S; Shi L; Zheng L; Wang R; Song J
    Mol Cancer; 2021 Dec; 20(1):167. PubMed ID: 34922544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
    Yin F; Huang X; Xuan Y
    Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANLN promotes carcinogenesis in oral cancer by regulating the PI3K/mTOR signaling pathway.
    Wang B; Zhang XL; Li CX; Liu NN; Hu M; Gong ZC
    Head Face Med; 2021 Jun; 17(1):18. PubMed ID: 34082790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.